Support PenkeMerck & Co. Inc - Trending symbols
Latest News of Merck & Co. Inc
| Date | Title | Read |
|---|---|---|
| 2025-09-11 19:42 | Merck (MRK) Announces Positive Phase 3 Results For 21-Valent Pneumococcal Vaccine | Read |
| 2025-09-10 20:33 | US drugmaker scraps plans for £1bn UK research centre | Read |
| 2025-09-10 06:59 | Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating | Read |
| 2025-09-05 20:17 | Companies tap US bond market for nearly $70 billion, starting September on a busy note | Read |
| 2025-09-05 11:50 | Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions | Read |
| 2025-08-19 19:29 | Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation | Read |
| 2025-08-19 17:37 | MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer | Read |
| 2025-08-17 08:30 | Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial | Read |
| 2025-08-14 01:05 | China pharma firms turn to local reagent suppliers to cut costs and delivery times | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 101,352 | 161,823 | 263,175 | -259,769 | 3,407 | 141,382 | 144,789 | -414,778 | -269,989 | |
| Tax Provision | 455,697 | 303,798 | 759,495 | -173,073 | 586,422 | 214,500 | 800,922 | -1,555,814 | -754,892 | |
| Income before Tax | 4,122,207 | -830,505 | 3,291,702 | -64,309 | 3,227,393 | 125,862 | 3,353,255 | -8,254,520 | -4,901,265 | |
| Net Income | 3,623,353 | -639,415 | 2,983,938 | -212,220 | 2,771,718 | -180,065 | 2,591,653 | -8,080,885 | -5,489,233 | |
| EBITDA | 4,655,053 | -882,871 | 3,772,182 | -568,675 | 3,203,507 | 293,065 | 3,496,572 | -8,101,097 | -4,604,524 | |
| Operating Income | 4,655,053 | -882,871 | 3,772,182 | -568,675 | 3,203,507 | 293,065 | 3,496,572 | -8,101,097 | -4,604,524 | |
| Net Income from Continuing Operations | 3,627,946 | -639,415 | 2,988,531 | -215,895 | 2,772,637 | -177,309 | 2,595,328 | -8,081,804 | -5,486,476 |
Comments
How you think about this?